Search Results for compound
Searching compound for 3 2 isopropyl 5 methylcyclohex oxy 1,2 propanediol returned 67383 results.
Displaying compounds 32101 - 32125 of 67383 in total
FDB022741
22204-53-1
(2S)-2-(6-methoxynaphthalen-2-yl)propanoic acid
Matched synonyms: … (+)-2-(6-Methoxy-2-naphthyl)propionate ... (+)-2-(Methoxy-2-naphthyl)-propionate ... (S)-2-(6-Methoxy-2-naphthyl)propanoate …
Matched iupac: … (2S)-2-(6-methoxynaphthalen-2-yl)propanoic acid …
Matched description: … Medicines; Naproxen is a member of the 2-arylpropionic acid (profen) family of NSAIDs. ... In Australia, small packets of lower-strength preparations of naproxen sodium are Schedule 2 Pharmacy …
Matched iupac: … (2S)-2-(6-methoxynaphthalen-2-yl)propanoic acid …
Matched description: … Medicines; Naproxen is a member of the 2-arylpropionic acid (profen) family of NSAIDs. ... In Australia, small packets of lower-strength preparations of naproxen sodium are Schedule 2 Pharmacy …
(46R)-46-[(2R,3S)-2-(3,4-dihydroxyphenyl)-3,5,7-trihydroxy-3,4-dihydro-2H-1-benzopyran-6-yl]-7,8,9,12,13,14,25,26,27,30,31,32,35,36,37-pentadecahydroxy-3,18,21,41,43-pentaoxanonacyclo[27.13.3.1³⁸,⁴².0²,²⁰.0⁵,¹⁰.0¹¹,¹⁶.0²³,²⁸.0³³,⁴⁵.0³⁴,³⁹]hexatetraconta-5(10),6,8,11,13,15,23,25,27,29,31,33(45),34,36,38-pentadecaene-4,17,22,40,44-pentone
Matched iupac: … 3,18,21,41,43-pentaoxanonacyclo[27.13.3.1³⁸,⁴².0²,²⁰.0⁵,¹⁰.0¹¹,¹⁶.0²³,²⁸.0³³,⁴⁵.0³⁴,³⁹]hexatetraconta-5( ... (46R)-46-[(2R,3S)-2-(3,4-dihydroxyphenyl)-3,5,7-trihydroxy-3,4-dihydro-2H-1-benzopyran-6-yl]-7,8,9,12,13,14,25,26,27,30,31,32,35,36,37 …
FDB001369
534-15-6
1,1-dimethoxyethane
Matched synonyms: … CH3CH(OCH3)2 ... 3-Methyl-2,4-dioxapentane …
FDB015040
59021-02-2
pyrazin-2-ylmethanethiol
Matched synonyms: … 2-Pyrazinemethanethiol ... 2-(Mercaptomethyl)pyrazine ... 2-Mercaptomethyl-pyrazine …
Matched iupac: … pyrazin-2-ylmethanethiol …
Matched iupac: … pyrazin-2-ylmethanethiol …
3,3,3a,6-tetrahydroxy-hexahydrofuro[3,2-b]furan-2-one
Matched iupac: … 3,3,3a,6-tetrahydroxy-hexahydrofuro[3,2-b]furan-2-one …
Matched description: … polycyclic compounds containing an isosorbide(1,4-Dianhydrosorbitol) moiety, which consists of two -oxolan-3- …
Matched description: … polycyclic compounds containing an isosorbide(1,4-Dianhydrosorbitol) moiety, which consists of two -oxolan-3- …
FDB018797
98975-04-3
(10S,11R,12R,13R,15R)-6-[5-({[(10R,11S,13R,14R,15S)-3,4,5,14,20,21,22-heptahydroxy-13-(hydroxymethyl)-8,17-dioxo-9,12,16-trioxatetracyclo[16.4.0.0^{2,7}.0^{10,15}]docosa-1(22),2,4,6,18,20-hexaen-11-yl]oxy}carbonyl)-2,3-dihydroxyphenoxy]-3,4,5,11,12,21,22,23-octahydroxy-8,18-dioxo-9,14,17-trioxatetracyclo[17.4.0.0^{2,7}.0^{10,15}]tricosa-1(23),2(7),3,5,19,21-hexaen-13-yl 3,4,5-trihydroxybenzoate
Matched synonyms: … Ethyl 2-acetylnonan-1-oate ... Nonanoic acid, 2-acetyl-, ethyl ester …
Matched iupac: … (10S,11R,12R,13R,15R)-6-[5-({[(10R,11S,13R,14R,15S)-3,4,5,14,20,21,22-heptahydroxy-13-(hydroxymethyl) ... -8,17-dioxo-9,12,16-trioxatetracyclo[16.4.0.0^{2,7}.0^{10,15}]docosa-1(22),2,4,6,18,20-hexaen-11-yl]oxy ... 3,4,5,11,12,21,22,23-octahydroxy-8,18-dioxo-9,14,17-trioxatetracyclo[17.4.0.0^{2,7}.0^{10,15}]tricosa-1(23),2( …
Matched iupac: … (10S,11R,12R,13R,15R)-6-[5-({[(10R,11S,13R,14R,15S)-3,4,5,14,20,21,22-heptahydroxy-13-(hydroxymethyl) ... -8,17-dioxo-9,12,16-trioxatetracyclo[16.4.0.0^{2,7}.0^{10,15}]docosa-1(22),2,4,6,18,20-hexaen-11-yl]oxy ... 3,4,5,11,12,21,22,23-octahydroxy-8,18-dioxo-9,14,17-trioxatetracyclo[17.4.0.0^{2,7}.0^{10,15}]tricosa-1(23),2( …
FDB022275
93-10-7
quinoline-2-carboxylic acid
Matched synonyms: … 2-Carboxyquinoline ... 2-Chinolincarbonsaeure ... 2-Quinolinecarboxylate …
Matched iupac: … quinoline-2-carboxylic acid …
Matched iupac: … quinoline-2-carboxylic acid …
N-(3-hydroxy-1-{[(2R,3R,4S,5R,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}octadec-4-en-2-yl)hexadecanamide
Matched iupac: … N-(3-hydroxy-1-{[(2R,3R,4S,5R,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}octadec-4-en-2-yl)hexadecanamide …
Matched description: … In infants, the disease is generally fatal before age 2. ... Symptoms begin between the ages of 3 and 6 months with irritability, fevers, limb stiffness, seizures ... Galactosylceramides are found in all nervous tissues, but they can amount to 2% of the dry weight of …
Matched description: … In infants, the disease is generally fatal before age 2. ... Symptoms begin between the ages of 3 and 6 months with irritability, fevers, limb stiffness, seizures ... Galactosylceramides are found in all nervous tissues, but they can amount to 2% of the dry weight of …
N-(3-hydroxy-1-{[(2R,3R,4S,5R,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}octadec-4-en-2-yl)octadecanamide
Matched iupac: … N-(3-hydroxy-1-{[(2R,3R,4S,5R,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}octadec-4-en-2-yl)octadecanamide …
Matched description: … In infants, the disease is generally fatal before age 2. ... Symptoms begin between the ages of 3 and 6 months with irritability, fevers, limb stiffness, seizures ... Galactosylceramides are found in all nervous tissues, but they can amount to 2% of the dry weight of …
Matched description: … In infants, the disease is generally fatal before age 2. ... Symptoms begin between the ages of 3 and 6 months with irritability, fevers, limb stiffness, seizures ... Galactosylceramides are found in all nervous tissues, but they can amount to 2% of the dry weight of …
N-(3-hydroxy-1-{[(2R,3R,4S,5R,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}octadec-4-en-2-yl)hexacos-17-enamide
Matched iupac: … N-(3-hydroxy-1-{[(2R,3R,4S,5R,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}octadec-4-en-2-yl)hexacos …
Matched description: … In infants, the disease is generally fatal before age 2. ... Symptoms begin between the ages of 3 and 6 months with irritability, fevers, limb stiffness, seizures ... Galactosylceramides are found in all nervous tissues, but they can amount to 2% of the dry weight of …
Matched description: … In infants, the disease is generally fatal before age 2. ... Symptoms begin between the ages of 3 and 6 months with irritability, fevers, limb stiffness, seizures ... Galactosylceramides are found in all nervous tissues, but they can amount to 2% of the dry weight of …
FDB028942
111956-48-0
N-(3-hydroxy-1-{[(2R,3R,4S,5R,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}octadec-4-en-2-yl)dodecanamide
Matched iupac: … N-(3-hydroxy-1-{[(2R,3R,4S,5R,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}octadec-4-en-2-yl)dodecanamide …
Matched description: … In infants, the disease is generally fatal before age 2. ... Symptoms begin between the ages of 3 and 6 months with irritability, fevers, limb stiffness, seizures ... Galactosylceramides are found in all nervous tissues, but they can amount to 2% of the dry weight of …
Matched description: … In infants, the disease is generally fatal before age 2. ... Symptoms begin between the ages of 3 and 6 months with irritability, fevers, limb stiffness, seizures ... Galactosylceramides are found in all nervous tissues, but they can amount to 2% of the dry weight of …
(2S)-1-[(14-methylhexadecanoyl)oxy]-3-[(17-methyloctadecanoyl)oxy]propan-2-yl 22-methyltetracosanoate
Matched iupac: … (2S)-1-[(14-methylhexadecanoyl)oxy]-3-[(17-methyloctadecanoyl)oxy]propan-2-yl 22-methyltetracosanoate …
(2S)-1-[(17-methyloctadecanoyl)oxy]-3-[(13-methyltetradecanoyl)oxy]propan-2-yl 22-methyltricosanoate
Matched iupac: … (2S)-1-[(17-methyloctadecanoyl)oxy]-3-[(13-methyltetradecanoyl)oxy]propan-2-yl 22-methyltricosanoate …
(2S)-1-[(14-methylhexadecanoyl)oxy]-3-[(17-methyloctadecanoyl)oxy]propan-2-yl 18-methylicosanoate
Matched iupac: … (2S)-1-[(14-methylhexadecanoyl)oxy]-3-[(17-methyloctadecanoyl)oxy]propan-2-yl 18-methylicosanoate …
(2R)-1-[(18-methylnonadecanoyl)oxy]-3-[(17-methyloctadecanoyl)oxy]propan-2-yl 18-methylicosanoate
Matched iupac: … (2R)-1-[(18-methylnonadecanoyl)oxy]-3-[(17-methyloctadecanoyl)oxy]propan-2-yl 18-methylicosanoate …
(2R)-1-[(19-methylicosanoyl)oxy]-3-[(17-methyloctadecanoyl)oxy]propan-2-yl 22-methyltricosanoate
Matched iupac: … (2R)-1-[(19-methylicosanoyl)oxy]-3-[(17-methyloctadecanoyl)oxy]propan-2-yl 22-methyltricosanoate …
(2S)-1-[(16-methylheptadecanoyl)oxy]-3-[(17-methyloctadecanoyl)oxy]propan-2-yl 22-methyltricosanoate
Matched iupac: … (2S)-1-[(16-methylheptadecanoyl)oxy]-3-[(17-methyloctadecanoyl)oxy]propan-2-yl 22-methyltricosanoate …
(2S)-1-[(14-methylhexadecanoyl)oxy]-3-[(18-methylnonadecanoyl)oxy]propan-2-yl 18-methylnonadecanoate
Matched iupac: … (2S)-1-[(14-methylhexadecanoyl)oxy]-3-[(18-methylnonadecanoyl)oxy]propan-2-yl 18-methylnonadecanoate …
(2S)-1-[(11-methyldodecanoyl)oxy]-3-[(18-methylnonadecanoyl)oxy]propan-2-yl 18-methylnonadecanoate
Matched iupac: … (2S)-1-[(11-methyldodecanoyl)oxy]-3-[(18-methylnonadecanoyl)oxy]propan-2-yl 18-methylnonadecanoate …
(2S)-1-[(10-methyldodecanoyl)oxy]-3-[(17-methyloctadecanoyl)oxy]propan-2-yl 22-methyltricosanoate
Matched iupac: … (2S)-1-[(10-methyldodecanoyl)oxy]-3-[(17-methyloctadecanoyl)oxy]propan-2-yl 22-methyltricosanoate …
(2S)-1-[(17-methyloctadecanoyl)oxy]-3-[(14-methylpentadecanoyl)oxy]propan-2-yl 18-methylicosanoate
Matched iupac: … (2S)-1-[(17-methyloctadecanoyl)oxy]-3-[(14-methylpentadecanoyl)oxy]propan-2-yl 18-methylicosanoate …
(2S)-1-[(17-methyloctadecanoyl)oxy]-3-[(10-methylundecanoyl)oxy]propan-2-yl 18-methylicosanoate
Matched iupac: … (2S)-1-[(17-methyloctadecanoyl)oxy]-3-[(10-methylundecanoyl)oxy]propan-2-yl 18-methylicosanoate …
(2S)-1-[(10-methyldodecanoyl)oxy]-3-[(17-methyloctadecanoyl)oxy]propan-2-yl 20-methylhenicosanoate
Matched iupac: … (2S)-1-[(10-methyldodecanoyl)oxy]-3-[(17-methyloctadecanoyl)oxy]propan-2-yl 20-methylhenicosanoate …
(2S)-1-[(18-methylnonadecanoyl)oxy]-3-[(12-methyltridecanoyl)oxy]propan-2-yl 18-methylnonadecanoate
Matched iupac: … (2S)-1-[(18-methylnonadecanoyl)oxy]-3-[(12-methyltridecanoyl)oxy]propan-2-yl 18-methylnonadecanoate …
(2S)-1-[(15-methylhexadecanoyl)oxy]-3-[(18-methylnonadecanoyl)oxy]propan-2-yl 18-methylnonadecanoate
Matched iupac: … (2S)-1-[(15-methylhexadecanoyl)oxy]-3-[(18-methylnonadecanoyl)oxy]propan-2-yl 18-methylnonadecanoate …